- Dr. Tejinder Singh is a Medical Oncologist and Hemato-oncologist with 10+ years of experience in the field.
- He acknowledged his role as a Reviewer in the Journal of Indian Paediatrics and actively participated in academic activities such as case presentations, seminars, and multi-disciplinary meetings.
- He completed his education in MBBS, Thanjavur, Tamil Nadu in 1998, MD – Medicine from Toppiwala Medical College, Mumbai in 2006, and lastly DM – Oncology from Kidwai Memorial Institute of Oncology, 2010.
- Dr. Tejinder Singh has accomplished nearly 20 autologous bone marrow transplantations and undergone advanced training in “Essentials of Palliative Care” along with multiple phases I, II, III clinical trials as well.
- He also has experience in the administration of chemotherapeutic agents for hematological and solid tumors, managing their toxicities, and management of immunocompromised patients,
- He has expertise in various aspects such as Acute Leukemia, Lymphomas, Bone marrow transplant, Multiple myeloma, Breast Cancer, etc.
Dr. Tejinder Singh
- Hematologist
- Consultant , MBBS, Diploma, MS, 10 years of experience
- Mumbai
Dr. Tejinder Singh
- Hematologist
- Consultant , MBBS, Diploma, MS, 10 years of experience
- Mumbai
Profile (Overview)
Specialities
Specialization
- Blood Cancer Treatment
- Salivary Gland Tumors
- Myxoid liposarcoma
- Oropharyngeal cancer
- Chronic lymphocytic leukemia
- Bone Marrow Transplant
Work Experience of Dr. Tejinder Singh
- Consultant, Apollo Hospitals, Mumbai
- Consultant, Fortis Hiranandani Hospital, Vashi
- Consultant, Fortis Hospital, Kalyan, Mumbai
Education
- MBBS, 1993, Thanjavur Medical College, The Tamil Nadu Dr. MGR Medical University
- MD, 2003, N Medical College, BYL Nair Hospital, University of Mumbai
- DM, 2007, Kidwai Memorial Institute of Oncology, Rajiv Gandhi University of Health Sciences, Bangalore
Awards
Paper Published
- Drug-induced Hepatitis: The commonest culprit in clinical practice. The Journal of General Medicine. April-June 2005.Vol.17 No.2.Page 29-33.
- Turbid serum in a patient of ALL on treatment. What to look for? Letter to the editor. Journal of Cancer Research and Therapeutics.Vol.5 Issue 3. July-Sept.2009.Page 219-220
- Primary Bone Lymphoma-A report of 2 cases and review of the literature. Journal of Cancer Research and Therapeutics. July-Sept 2010.Vol 6.Issue 3.Page 296-298.
- Hepatoblastoma: Experience from a single center. Indian Journal of Cancer. July-Sept 2010; 47(3):314-6.
- Primary B cell non-Hodgkin’s lymphoma of the tongue. Letter to the editor. Indian J Cancer. Jan-March 2010; 47(1):84-6.
- Rectal carcinoma metastasizing to the breast: A case report and review of the literature. Journal of Cancer Research and Therapeutics – October-December 2009 – Volume 5 – Issue 4.310-312.
- IgA Plasma cell Leukemia. Journal of Laboratory Physicians. Jan-Jun 2009. Vol 1. Issue 1. Page 19-21.
- Use of Port-A-Cath in pediatric cancer patients: Experience from a tertiary cancer center in South India. J Clin Oncol 27, 2009 (suppl; Abstr e20747).
- Blindness as an initial presentation of rectal cancer with brain metastases. Letter to the editor. The Saudi Journal of Gastroenterology. Vol. 15. Number 1. Jan 2009.Page 63-64.
